Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Huanglian Jiedu Pills for excess heat fire-toxicity syndrome
ChiCTR1900027258Phase 2Completed
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Nov 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Huanglian Jiedu Decoction in Oral ulcer, gingivitis and acute pharyngitis (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Main symptom disappearance rate at Day 5, Vital signs at Day 5 and 1 more. Started Nov 2019; status: completed.
02
Drugs
Huanglian Jiedu Decoction
03
Conditions
Oral ulcergingivitisacute pharyngitis
Beyond the preview
Go deeper on ChiCTR1900027258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027258.